Lawmakers are continuing to debate how best to regulate prescription drug costs after President Donald Trump implemented pharmaceutical tariffs earlier this month.
The move was widely seen as a way for Trump to enact his drug pricing plan, called Most Favored Nation, without having to go through Congress. The administration is imposing tariffs up to 100% on some drugs made in other countries by companies that don’t have tariff deals with the US and haven’t agreed to Most Favored Nation deals with the White House. Trump has also been pushing Congress to codify into law his proposal to link US ...